Regis Lassalle
Overview
Explore the profile of Regis Lassalle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1063
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pajouheshnia R, Gini R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5871.
PMID: 39145406
Purpose: Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and...
2.
Gini R, Pajouheshnia R, Gutierrez L, Swertz M, Hyde E, Sturkenboom M, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5884.
PMID: 39145403
No abstract available.
3.
Thurin N, Grelaud A, Grolleau A, Bernard M, Bignon E, Blin P, et al.
Pharmacoepidemiol Drug Saf
. 2024 Mar;
33(4):e5781.
PMID: 38527971
Purpose: This paper aims to introduce an algorithm designed to identify Venous Thromboembolism (VTE) in the French National Healthcare Database (SNDS) and to estimate its positive predictive value. Methods: A...
4.
Hurley E, Geisler B, Lupattelli A, Poblador-Plou B, Lassalle R, Jove J, et al.
Eur J Clin Pharmacol
. 2024 Feb;
80(5):707-716.
PMID: 38347228
Purpose: The COVID-19 pandemic has impacted medication needs and prescribing practices, including those affecting pregnant women. Our goal was to investigate patterns of medication use among pregnant women with COVID-19,...
5.
Blin P, Joubert M, Jourdain P, Zaoui P, Guiard E, Sakr D, et al.
Cardiovasc Diabetol
. 2024 Jan;
23(1):22.
PMID: 38195491
Background: Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes. The objective...
6.
Baulain R, Jove J, Sakr D, Gross-Goupil M, Rouyer M, Puel M, et al.
Cancer Innov
. 2023 Dec;
2(1):52-64.
PMID: 38090372
Background: Healthcare pathways of patients with prostate cancer are heterogeneous and complex to apprehend using traditional descriptive statistics. Clustering and visualization methods can enhance their characterization. Methods: Patients with prostate...
7.
Daveluy A, Bryan M, Miremont-Salame G, Lassalle R, Lacueille C, Grelaud A, et al.
Fundam Clin Pharmacol
. 2023 Oct;
38(2):389-397.
PMID: 37864449
Background: The combination dextropropoxyphene/paracetamol (DXP/P) was the most prescribed opioid analgesic until its withdrawal in 2011. Objectives: This study investigated dispensations of analgesics in chronic users of DXP/P during the...
8.
Bosco-Levy P, Briot K, Mehsen-Cetre N, OKelly J, Desamericq G, Abouelfath A, et al.
JBMR Plus
. 2023 Sep;
7(9):e10789.
PMID: 37701145
Although drugs for osteoporosis have been demonstrated to be effective in reducing fracture risk in placebo-controlled clinical trials, data on effectiveness in real-world practice is limited. Data from the French...
9.
Bosco-Levy P, Boutmy E, Guiard E, Foch C, Lassalle R, Favary C, et al.
Pharmacoepidemiol Drug Saf
. 2023 Aug;
32(12):1421-1430.
PMID: 37555380
Purpose: The objective was to compare the risk of malignancies in real-world settings between exclusive immunosuppressant (IS) and immunomodulator (IM) use in multiple sclerosis (MS). Methods: A nested case-control study...
10.
Tan E, Robinson D, Jodicke A, Mosseveld M, Bodkergaard K, Reyes C, et al.
Osteoporos Int
. 2023 Jul;
34(10):1771-1781.
PMID: 37436441
Purpose: To characterise the patients prescribed osteoporosis therapy and describe the drug utilization patterns. Methods: We investigated the treatment patterns of bisphosphonates, denosumab, teriparatide, and selective estrogen receptor modulators (SERMs)...